Chapel Hill · Biotech · North Carolina

13 Chapel Hill biotech startups

As of November 2026, Triangle Startups tracks 13 biotech startups headquartered in Chapel Hill, home to the University of North Carolina at Chapel Hill. In the twelve months to November 2026, Chapel Hill biotech startups disclosed $1.3 million across 4 funding rounds.

Latest recorded activity

Directory snapshot

Chapel Hill biotech startups by stage

Of 5 startups with a recorded funding stage, 5 are at grant, pre-seed, or seed.

tracked startups
13
hiring now
0
grant through seed
5
By stageSeed3Grant1Pre-seed1

All 13 biotech startups headquartered in Chapel Hill

B

BioKier

Biotech

Develops treatments for diabetes and cardiometabolic disease based on the effects of gastric bypass surgery.

D

DelAQUA Pharmaceuticals

Biotech

Develops a polymer micelle platform that makes poorly soluble drugs more soluble, stable, and bioavailable.

E

Enfuego Therapeutics

Biotech

Develops peptide-oligonucleotide conjugate siRNAs for solid tumors.

GeneVentiv Therapeutics

GeneVentiv Therapeutics

Biotech · Pre-seed

UNC Chapel Hill Gene Therapy Center spinout developing GENV HEM, a universal gene therapy for all types of hemophilia (including patients with inhibitors to clotting factors); pipeline expanded to include a Pompe disease program in 2025.

InoKare Therapeutics

InoKare Therapeutics

Biotech · Seed

Small-molecule inhibitors targeting obesity and metabolic disorders

iOrganBio

iOrganBio

Biotech · Seed

AI-powered cell manufacturing platform for human cell production

M

M34

Biotech

Develops gene therapies that cross the blood-brain barrier for neurological disease, and nonviral gene vectors for hemophilia A.

P

Persistence Therapeutics

Biotech · Seed

Implantable synthetic lymph node for CAR-T cell generation

Q

Quanticision Diagnostics

Biotech

Develops quantitative protein biomarker assays and companion diagnostics for cancer therapy using its Quantitative Dot Blot platform.

S

Sollus Therapeutics, Inc.

Biotech

Develops immune cell therapies for oncology and autoimmunity, including a screening platform for chimeric antigen receptor optimization.

T

TransChromix LLC

Biotech · Grant

Chapel Hill therapeutics company developing brain-penetrant small molecules for Alzheimer's disease and other conditions using chromatin-activity-based chemoproteomics.

T

Triangle Biotechnology

Biotech

Develops ultrasound-activated reagents and microplate sonication tools that speed DNA and chromatin sample prep for sequencing and epigenetic assays.

T

Tripill Biotechnology Corp.

Biotech

Develops targeted radionuclide therapeutics, including a radiolabeled PSMA agent designed for low salivary gland uptake and astatine-211 agents for melanoma.

Browsing is free. Opening a company shows the basics; founders, funding, and signals are in the full profile behind a free account. Open roles across Triangle companies are tracked on the jobs page. Numbers refresh from the database.